HCA Healthcare is upgraded to "Buy" after recent underperformance, with shares now reflecting payer mix and policy headwinds. HCA's Q2 results beat expectations due to a $400 million one-time Medicaid payment, masking underlying margin compression from a worsening payer mix. Guidance was cut, with 2026 EPS now seen at $29–$30 (excluding windfall: ~$28), and free cash flow run-rate at ~$6 billion, reflecting persistent policy pressures.
HCA Healthcare stock falls after the hospital chain operator lowers its full-year profit outlook as uninsured patients rise in the second quarter.
The for-profit operator of healthcare facilities scaled back financial guidance for the year following payer mix shifts due to health insurance exchanges.
| Health Care Providers & Services Industry | Healthcare Sector | Samuel N. Hazen CEO | XDUS Exchange | US40412C1018 ISIN |
| US Country | 320,000 Employees | 30 Jun 2026 Last Dividend | - Last Split | 10 Mar 2011 IPO Date |
HCA Healthcare, Inc., with its extensive network of subsidiaries, stands as a prominent owner and operator of hospitals and healthcare-related facilities across the United States. Established in 1968 and headquartered in Nashville, Tennessee, HCA Healthcare began as HCA Holdings, Inc. It has grown to operate a wide range of healthcare facilities, including general and acute care hospitals that provide comprehensive medical and surgical services. These services cater to both inpatient and outpatient needs, with a strong emphasis on quality care across various specialties such as intensive care, cardiac care, diagnostics, and emergency services. The organization focuses on delivering high-quality patient care and enhancing the health of the communities it serves.
HCA Healthcare, Inc. offers a broad spectrum of healthcare services through its extensive network of facilities, including: